Are rapid immunoassays for in vivo detection of toxin A sufficient for diagnostic purposes of Clostridium difficile-associated diseases?

Anaerobe

Volumn 6, Issue 1, 2000, Pages 15-19

  Martirosian, Gayane ^a   Van Belkum, Alex ^b   Pituch, Hanna ^a   Obuch Woszczatyński, Piotr ^a   Meisel Mikolajczyk, Felicja ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLOSTRIDIUM DIFFICILE TOXIN A;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIARRHEA; FECES ANALYSIS; FEMALE; GENOTYPE; HUMAN; IMMUNOASSAY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RIBOTYPING;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

EID: 0034070655     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1006/anae.1999.0312     Document Type: Article

References (18)

1. Mastrantonio P., Pantosti A., Cequetti M., Moliari A., Donelli G. C. difficile: an update on virulence mechanisms. Anaerobe. 2:1996;337-340.
2. Bartlett J. G. Antibiotic-associated diarrhoea. Clin Inf Dis. 12:1992;243-251.
3. Fiorentini C., Malorni W., Paradisi S., Guiliano M., Mastrantonio P., Donelli G. Interaction of C. difficile toxin A with cultured cells: cytosceletal changes and nuclear polarization. Infect Immun. 58:1990;2329-2336.
4. Borriello S. P. Pathogenesis of Clostridium difficile infection. JAC. 41:1998;13-19.
5. Meisel-Mikolajczyk F., Martirosian G., Marianowski L., Dworczynska M., Cwyl-Zembrzurska L. C. difficile in a maternity hospital. Int J Feto-Maternal Med. 5:1992;173-177.
6. George R. H., Sutter V. L., Citron D., Finegold S. M. Selective and differential medium for isolation of C. difficile. J Clin Microbiol. 9:1979;214-219.
7. Martirosian G., Kuipers S., Verbrugh H., van Belkum A., Meisel-Mikolajczyk F. PCR ribotyping and arbitrarily primed PCR for typing strains of C. difficile from a polish maternity hospital. J Clin Microbiol. 33:1995;2016-2021.
8. Meisel-Mikolajczyk F., Martirosian G., Tang Y., Silva J. Jr. Genotyping of C. difficile isolates from a hospital in Warsaw: a preliminary study. Int J Infect Dis. 2:1997;88-90.
9. Martirosian G. C. difficile: epidemiology, diagnostics. Post. Mikrobiol. 4:1997;407-418.
10. Brazier J. S. The epidemiology and typing of C. difficile. JAC. 41:1998;47-57.
11. Rothman S. W. Technique for measuring 50% end points in cytotoxicity assay for C. difficile toxins. J Clin Pathol. 39:1986;672-676.
12. Borriello S. P., Wren B. W., Hyde S., Seddon S. V., Sibbons P., Krishna M. M., Tabaqchali S., Manek S., Price A. B. Molecular, immunological and biological characterization of a toxin A-negative, toxin B-positive strain of C. difficile. Infect Immun. 60:1992;4192-4199.
13. Gumerlock P. H., Tang Y. J., Weiss J. B., Silva J. Jr. Specific detection of toxigenic strains of C. difficile in stool specimens. J Clin Microbiol. 31:1993;507-511.
14. Tang T. J., Gumerlock P. H., Weiss J. B., Silva J. Jr. Specific detection of C. difficile toxin A gene sequences in clinical isolates. Mol Cell Probes. 8:1994;463-467.
15. Pituch H., Obuch-Woszczatyński P., Rouyan Gh., Martirosian G., Meisel-Mikolajczyk F. Detection of toxin producing C. difficile using rapid diagnostic methods. Med Dosw Mikrobiol. 50:1998;55-61.
16. Van Belkum A. DNA fingerprinting of medically important microorganisms by use of PCR. Clin Microbiol Rev. 7:1994;174-178.
17. Tabaqchali S., Jumaa P. Diagnosis and management of Clostridium difficile infection. BMJ. 310:1995;1375-1380.
18. Rupnik M., Avensani V., Janc M., von Eichel-Streiber C., Delmee M. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol. 36:1998;2240-2247.